CHD1L Recombinant Antibody
Applications
Reactivity
Predicted Reactivity
| Overview | |
| Catalog # | bsm-61977r-100uL |
| Product Name | CHD1L Recombinant Antibody |
| Applications |
WB
FCM
IF(ICC)
IP
|
| Reactivity | Human |
| Predicted Reactivity | Mouse |
| Specifications | |
| Conjugation | Unconjugated |
| Host | Rabbit |
| Source | KLH conjugated synthetic peptide derived from human CHD1L |
| Clonality | Recombinant |
| Isotype | IgG |
| Concentration | Lot dependent |
| Purification | Purified by Protein A. |
| Storage Buffer | 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| Storage Condition | Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles. |
| Target | |
| Gene ID | 9557 |
| Swiss Prot | Q86WJ1 |
| Subcellular location | Nucleus |
| Synonyms | ALC1; chd1l; CHDL. |
| Background | ATP-dependent chromatin remodeler that mediates chromatin-remodeling following DNA damage.Recruited to DNA damage sites through interaction with poly-ADP-ribose: specifically recognizes and binds histones that are poly-ADP-ribosylated on serine residues in response to DNA damage. |
| Application Dilution | |
| WB | 1:500-2000 |
| FCM | FCM1:50-100 |
| IF(ICC) | IFICC1:50-200 |
| IP | IP1:20-50 |
Frequently asked questions
Which applications is CHD1L Recombinant Antibody (bsm-61977R) validated for, and at what dilution?
bsm-61977R is validated for WB(WB) (1:500-2000); FCM(FCM) (1:50-100); IF(ICC)(IF(ICC)) (1:50-200); IP(IP) (1:20-50). These are recommended starting dilutions; optimal dilutions should be determined by the end user.
Which species does CHD1L Recombinant Antibody (bsm-61977R) react with?
Tested reactivity: Human. Predicted reactivity (expected from sequence homology but not yet tested): Mouse.
How should bsm-61977R be stored?
Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles. Storage buffer: 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol
What immunogen was used to raise CHD1L Recombinant Antibody (bsm-61977R)?
KLH conjugated synthetic peptide derived from human CHD1L